Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
70
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards43
43
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature38
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice33
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life32
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases30
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population30
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years30
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy30
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis29
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants29
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment28
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies28
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease28
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease28
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method27
Platelet Function Testing: Update and Future Directions26
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient26
Testing for Lupus Anticoagulants24
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies24
Fifty Years of Fibrinogen Structure and Function21
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review21
Application of ACR/EULAR Classification Criteria in real life: thrombotic patients positive for Lupus Anticoagulant only21
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review21
Platelet Activation and Thrombosis in COVID-1921
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review20
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings19
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives19
Editorial Compilation—XIII19
The History of Rare Bleeding Disorders17
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey17
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice17
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future16
Toward 50 Years of Seminars in Thrombosis and Hemostasis16
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L16
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism16
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles15
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III14
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System14
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment14
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase14
14
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?14
Bleeding in patients with renal impairment – a current perspective14
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review14
14
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment14
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management14
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories13
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu13
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans13
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale13
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic12
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?12
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data12
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency12
12
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance12
Automation in Platelet Function Testing: Current Challenges and Future Directions12
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis12
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer12
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics12
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review12
Colchicine as a Modulator of Platelet Function: A Systematic Review11
Bleeding Scoring Systems in Neonates: A Systematic Review11
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?11
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls11
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection11
A Historical Perspective on the Reversal of Anticoagulants11
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review11
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives11
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials11
Venous Thromboembolism in Children: The Rivaroxaban Experience11
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications11
Editorial Compilation XIV11
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities11
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis11
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis10
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome10
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)10
10
Editorial Compilation XI10
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy10
Precision Medicine in Rare Bleeding Disorders10
Thrombin Generation Assays: What are the Current Clinical Applications?10
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia10
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions10
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions10
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice10
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?9
The Role of Platelets in Atherosclerosis: A Historical Review9
9
Hemostasis Testing in the Emergency Department: A Narrative Review9
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature9
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations9
Do we Have the Gut to Beat Thrombosis?9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure9
Non-factor Therapies for Hemophilia: Achievements and Perspectives9
Platelet Physiology9
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays9
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism9
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines9
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review9
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass9
NETosis in Acute Thrombotic Disorders8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards8
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond8
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction8
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives8
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care8
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost8
8
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality8
Internal Quality Control in Hemostasis Assays7
One Hundred Years of Congenital Fibrinogen Disorders7
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-197
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets7
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up7
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke7
Crucial Stepping Stones in Platelet History7
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies7
7
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics7
The More Recent History of Hemophilia Treatment7
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?7
Evolution of Antiphospholipid Syndrome7
7
Next-Generation Sequencing and Emerging Technologies*7
0.16910314559937